PRENATAL-DIAGNOSIS OF MEDIUM-CHAIN ACYL-COA DEHYDROGENASE (MCAD) DEFICIENCY IN A FAMILY WITH A PREVIOUS FATAL CASE OF SUDDEN UNEXPECTED DEATH IN CHILDHOOD
N. Gregersen et al., PRENATAL-DIAGNOSIS OF MEDIUM-CHAIN ACYL-COA DEHYDROGENASE (MCAD) DEFICIENCY IN A FAMILY WITH A PREVIOUS FATAL CASE OF SUDDEN UNEXPECTED DEATH IN CHILDHOOD, Prenatal diagnosis, 15(1), 1995, pp. 82-86
Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is a potentially
fatal inherited disease with a carrier frequency of approximately 1:1
00 in most Caucasian populations. The disease is implicated in sudden
unexpected death in childhood. A prevalent disease-causing point mutat
ion (A985G) in the MCAD gene has been characterized, thus rendering di
agnosis easy in the majority of cases. Since the clinical spectrum of
MCAD deficiency ranges from death in the first days of life to an asym
ptomatic life, there are probably other genetic factors-in addition to
MCAD mutations-involved in the expression of the disease. Thus, famil
ies who have experienced the death of a child from MCAD deficiency mig
ht have an increased risk of a seriously affected subsequent child. In
such a family we have therefore performed a prenatal diagnosis on a c
horionic villus sample by a highly specific and sensitive polymerase c
hain reaction (PCR) assay for the G985 mutation. The analysis was posi
tive and resulted in abortion. We verified the diagnosis by direct ana
lysis on blood spots and other tissue material from the aborted fetus
and from family members.